2-Chloro-4-(pyridin-3-yl)-1,3,5-triazine

Catalog No.: 
ACTNAN652
CAS No.: 
1053656-03-3
Molecular Formula: 
C8H5ClN4
Molecular Weight: 
192.61
2-Chloro-4-(pyridin-3-yl)-1,3,5-triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$139.00InquiryInquiry
5g96%$688.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-4-(pyridin-3-yl)-1,3,5-triazine
IUPAC Name2-chloro-4-(pyridin-3-yl)-1,3,5-triazine
MDL No.MFCD09864962
Molecular FormulaC8H5ClN4
Molecular Weight192.61
SMILESClC1=NC(C2=CC=CN=C2)=NC=N1
InChI KeyICCJPZWJQCTSHD-UHFFFAOYSA-N
Synonym2-CHLORO-4-PYRIDIN-3-YL-1,3,5-TRIAZINE;2-Chloro-4-(3-pyridyl)-1,3,5-triazine;1,3,5-Triazine, 2-chloro-4-(3-pyridinyl)-
CAS No.1053656-03-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTNAN652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUKYQ028 route compound structure diagram
    ACUKYQ0282831-66-5In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACTNAN652 route product structure diagram
    ACTNAN6521053656-03-3
Inquiry

2. ACTNAN652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACTNAN652 route product structure diagram
    ACTNAN6521053656-03-3
Inquiry

3. ACTNAN652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUKYQ028 route compound structure diagram
    ACUKYQ0282831-66-5In Stock
  4. Then
  5. ACTNAN652 route product structure diagram
    ACTNAN6521053656-03-3
Inquiry

Comments (0)